Sera Prognostics (SERA) director reports 1,560-share sale via 10b5-1 plan

Rhea-AI Filing Summary

Sera Prognostics, Inc. director reported an open-market sale of company stock. On 12/08/2025, the reporting person sold 1,560 shares of Class A Common Stock at a weighted average price of $3.05 per share, with individual trade prices ranging from $2.99 to $3.11. The sale was made under a Rule 10b5-1 trading plan that the insider adopted on June 10, 2025. After this transaction, the insider beneficially owns 19,593 shares of Sera Prognostics common stock in direct form.

Insider Trade Summary

Net Seller: 1,560 shares ($4,758)

Net Sell 1 txn

Insider Lawrence Sandra AJ

Role Director

Sold 1,560 shs ($5K)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock	1,560	$3.05	$5K

Holdings After Transaction: Class A Common Stock — 19,593 shares (Direct)

Footnotes (1)

1. The transaction(s) reported on this Form 4 was/were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2025. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.99 to $3.11, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lawrence Sandra AJ

(Last) (First) (Middle)

C/O SERA PROGNOSTICS, INC.

2749 EAST PARLEYS WAY, SUITE 200

(Street)

SALT LAKE CITY UT 84109

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SERA PROGNOSTICS, INC. [ SERA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/08/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	12/08/2025		S(1)		1,560	D	$3.05(2)	19,593	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The transaction(s) reported on this Form 4 was/were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2025.

2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.99 to $3.11, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

	/s/ Benjamin G. Jackson, Attorney-in-fact	12/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Sera Prognostics (SERA) disclose?

A director of Sera Prognostics, Inc. reported selling 1,560 shares of Class A Common Stock in an open-market transaction on 12/08/2025.

At what price were the SERA shares sold in this Form 4 filing?

The shares were sold at a weighted average price of $3.05 per share, in multiple trades at prices ranging from $2.99 to $3.11.

How many Sera Prognostics shares does the insider own after this transaction?

Following the reported sale, the director beneficially owns 19,593 shares of Sera Prognostics Class A Common Stock in direct ownership.

Was the SERA insider sale made under a Rule 10b5-1 trading plan?

Yes. The filing states the transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2025.

What is the insider’s relationship to Sera Prognostics (SERA)?

The reporting person is identified as a Director of Sera Prognostics, Inc. and filed the report as a single reporting person.

Where were communications for the Sera Prognostics insider directed?

The address listed for the reporting person is C/O Sera Prognostics, Inc., 2749 East Parleys Way, Suite 200.